Dr Reddy’s receives tentative FDA approval for generic lenacapavir HIV-prevention injection
Science & ClimateWell-covered
|
The Facts
- The FDA granted Dr Reddy’s tentative approval for generic lenacapavir for HIV prevention.
- Lenacapavir is administered as an injection twice a year.
- The approval was granted through the FDA’s PEPFAR program.
- The generic is intended for 120 low- and middle-income countries outside the United States.
- The drug is expected to cost $40 per person annually in eligible countries.
- Dr Reddy’s expects initial supplies before the end of 2026.
- Broader rollout in eligible countries is planned for 2027.
Context
What is lenacapavir used for?
Lenacapavir is a long-acting injectable medicine used as pre-exposure prophylaxis, or PrEP, to reduce the risk of sexually acquired HIV-1. Hindu Times of India cnbctv18.com
Does tentative approval authorize sales in the United States?
No. Reuters reported that the tentative approval supports sales in covered low- and middle-income countries but does not yet authorize sales in the United States. Reuters Deutsche Welle
Why could the injection affect HIV-prevention access?
It is dosed twice yearly rather than daily, and sources report it is expected to be priced at $40 annually in the eligible countries. Independent U.S. News & World R… CBC News
Where Left and Right agree
Left and right largely agree on this one.
- What both sides accept
- Affordable, accessible rollout of generic lenacapavir across 120 countries matters as much as the drug's approval itself.
- Where Left and Right differ in emphasis
- Both prize the $40 price point; one frames it as access justice for exposed populations, the other as fiscal discipline demanding accountability.
- Watch for
- Watch whether Dr Reddy's hits its stated timeline of initial supplies reaching countries before the end of 2026, with broader rollout in 2027.The Times of India
How left and right read it
Left says
A prevention tool only counts if the people most exposed to HIV can actually get it, which is why pricing it at $40 a year across 120 low- and middle-income countries matters as much as the science behind it. Two shots a year that all but erased new infections in trials is what public health exists to deliver.
“However, the injections provide a far more convenient alternative to daily tablets due to their reduced administration frequency, and they virtually eliminated new HIV cases during two groundbreaking clinical trials involving individuals at high risk.” — The Independent
Is this how the left would actually put it?
Right says
Generosity abroad is defensible only when each dollar is disciplined by price, and a generic lenacapavir expected to run $40 per person a year in eligible countries meets that test. The approval itself is a regulatory judgment through PEPFAR for 120 countries outside our own, not an open-ended check, so delivery is now the supplier's burden to prove. Hold that schedule, and that price.
Is this how the right would actually put it?
The receipts — 100 sources
Wire services (7)
Independent coverage (93)
La JornadaLa Jornada: "El fin del VIH, cercano": aprueban fármaco gené...
AccessWDUNPromising new HIV-prevention drug is hard to find where it's...
Redacción MédicaLa Agencia de Medicamentos de EEUU aprueba un tratamiento ge...
The New Indian ExpressPromising new HIV-prevention drug is hard to find where it's...
TheColu.mnAffordable HIV Prevention Shot Approved by US Regulators - T...
mediacongo.netActualité | VIH : l'agence américaine du médicament approuve...
eHealth MagazineDr Reddy's Gets USFDA Tentative Nod for Generic Lenacapavir
Express PharmaUS FDA grants tentative approval for Dr. Reddy's twice-yearl...
allAfricaCentral African Republic: U.S. FDA Approves First Generic In...
NOGOYA TIMESAprobaron un tratamiento preventivo contra el VIH: cuánto co...
thesun.myUS approves cheap generic HIV shot for poorer countries
Medios ObsonEU aprueba genérico de inyección preventiva contra el VIH - ...
GHANA MMAGhana AIDS Commission Launches Youth Desk To Tackle Infectio...
MedindiaDr. Reddy's Wins FDA Nod for Generic HIV Prevention Drug
New Zealand DoctorTurning Aotearoa red for World AIDS Day
Economie MatinVIH : la FDA ouvre la voie au générique à 40 dollars par an,...
MeduzaRussia's HIV epidemic is worsening despite official claims t...
Sentinel ColoradoApproval of a cheap version of HIV-prevention shot lenacapav...
science.orgU.S. approval of cheap, generic HIV prevention shot may boos...
CBC NewsCheap version of HIV-prevention shot raising hope in low-inc...
Último SegundoEUA aprovam genérico de lenacapavir para prevenção do HIV
TerraEUA aprovam genérico de lenacapavir para prevenção do HIV
Deutsche WelleEUA aprovam genérico de lenacapavir para prevenção do HIV
EL IMPARCIAL | Noticias de México y el mundoFDA aprueba la primera versión genérica de lenacapavir, la i...
BioBioChileAprueban revolucionaria inyección contra el VIH: reduce 99.9...
Noticias RCN | Noticias de Colombia y el MundoEE.UU. aprueba tratamiento genérico contra el VIH: costará 4...
OsunDefenderUS Approves Cheap Version Of HIV Prevention Shot
3NewsGhana AIDS Commission launches Youth Desk to tackle HIV infe...
The Manila timesDOH includes HIV testing in YAKAP program expansion
FirstpostIndia's Dr Reddy's gets US nod for $40 generic HIV preventio...
DER STANDARDGenerikum von HIV-Prophylaxe-Injektion erhält US-Genehmigung
cnbctv18.comDr Reddy's Laboratories gets USFDA tentative nod for twice-y...
Deutsche WelleEEUU aprueba versión económica de tratamiento preventivo con...
Yahoo!EE.UU. aprueba versión económica de tratamiento preventivo c...
7sur7Avancée majeure contre le VIH: un traitement préventif appro...
Südtirol NewsGenerikum von HIV-Prophylaxe-Spritze erhält US-Genehmigung
Vienna OnlineUS-Genehmigung für günstiges HIV-Generikum Lenacapavir
unternehmen-heute.deNur 40 Dollar pro Jahr: Generikum von HIV-Prophylaxe-Spritze...
stern.deNur 40 Dollar pro Jahr: Generikum von HIV-Prophylaxe-Spritze...
Minuto30.com¡Avance contra el VIH! Aprueban genérico de inyección semest...
RTBFAccès aux médicaments : feu vert américain pour un traitemen...
La Libre.beFeu vert américain pour un traitement abordable contre le VI...
Cuba Headlines Digital EditionTwo Annual Injections to Prevent HIV: FDA Approves $40 Gener...
Le Telegramme" Une avancée extraordinaire pour la santé mondiale " : feu ...
O TEMPOEUA aprovam versão genérica de injeção contra HIV que custa ...
FranceinfoLes Etats-Unis approuvent la version générique d'un traiteme...
CiberCubaDos inyecciones al año para prevenir el VIH: Genérico de 40 ...
SudOuest.frLutte contre le sida : les États-Unis approuvent la version ...
guardian.co.ttApproval of a cheap version of HIV-prevention shot lenacapav...
The GuardianUS approves $40 generic HIV prevention shot for 120 Countrie...
Nuestras Voces▷ EE. UU. da luz verde al genérico para prevenir el VIH con ...
Le ProgrèsÉtats-Unis. VIH : l'agence du médicament approuve la version...
Jornal de BrasíliaEUA aprova versão genérica de tratamento preventivo contra H...
EstadãoEUA aprovam versão genérica de tratamento preventivo contra ...
Yahoo NewsUS approves cheap generic of breakthrough HIV shot for poore...
ExameEUA aprovam genérico de medicamento que previne HIV e custa ...
The IndependentGeneric HIV prevention shot approved in major step to end gl...
Capital FM KenyaGeneric HIV prevention injection moves closer to 120 countri...
The HinduDr. Reddy's secures U.S. FDA tentative nod for HIV drug lena...
STATFDA OKs generic HIV prevention shot, widening access for low...
Le ParisienLes États-Unis approuvent la version générique de lenacapavi...
News18Dr Reddy's gets USFDA tentative nod for HIV prevention drug
Yahoo NewsUS approves cheap generic version of world's only twice-year...
DH.beLes États-Unis approuvent la version générique d'un traiteme...
France Antilles MqeFeu vert américain pour un traitement abordable contre le VI...
Business StandardUS FDA grants tentative nod to Dr Reddy's twice-yearly HIV p...
The TribuneApproval of India-made version of HIV-prevention shot raises...
Radio RFJLa FDA approuve la version générique d'un traitement contre ...
SWI swissinfo.chLa FDA approuve la version générique d'un traitement contre ...
La LibertéVIH. La FDA approuve la version générique d'un traitement co...
MoneyControlDr Reddy's gets USFDA nod for generic twice-a-year HIV preve...
@businesslineDr Reddy's injectable lenacapavir for HIV prevention gets te...
United News of IndiaDr Reddy's gets tentative USFDA nod for twice-y... | UNI Ind...
RTL TodayUS approves cheap version of breakthrough HIV prevention sho...
T13 (teletrece)Estados Unidos aprueba versión genérica de tratamiento preve...
IOLGeneric lenacapavir HIV prevention shot wins US FDA approval
El Diario de JuárezAprueba EU versión económica de tratamiento para VIH
The Times of IndiaDr Reddy's gets USFDA nod for first generic twice-yearly inj...
Orlando SentinelApproval of a cheap version of HIV-prevention shot lenacapav...
NewsdayApproval of a cheap version of HIV-prevention shot lenacapav...
CRHoy.com | Periodico Digital | Costa Rica Noticias 24/7EE. UU. aprueba versión genérica de inyección preventiva con...
TV360 NigeriaLASG procures HIV drug for over 147,000 patients
UNFPA ESARORecommit to equality to address HIV as a major global public...
TribLIVEApproval of a cheap version of HIV-prevention shot lenacapav...
U.S. News & World ReportApproval of a Cheap Version of HIV-Prevention Shot Lenacapav...
Court House News ServiceApproval of a cheap version of HIV-prevention shot lenacapav...
HealthwiseLASG procures HIV drug for over 147,000 patients
brusselstimes.com'I have HIV. Now what do I do?' A Brussels man on life after...
TheColu.mnBavaria's Health Minister Urges HIV Testing - TheColu.mn
MedscapeHigh HIV Viral Load Before Birth May Raise Infant Risk
www.diariolibre.comEE.UU. aprueba versión económica de tratamiento preventivo c...
Correio do povoEUA aprova versão genérica de tratamento preventivo contra H...
Punch NewspapersLASG procures HIV drug for over 147,000 patients
The news, read by both sides.
The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.